276 related articles for article (PubMed ID: 34534506)
1. Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years.
Sykes PH; Simcock BJ; Innes CR; Harker D; Williman JA; Whitehead M; van der Griend RA; Lawton BA; Hibma M; Fitzgerald P; Dudley NM; Petrich S; Eva L; Bergzoll C; Kathuria J; McPherson G; Tristram A; Faherty J; Hardie D; Robertson A; Robertson V; Pather S; Wrede CD; Gastrell F; Fentiman G; John M; White E; Parker C; Sadler L
Am J Obstet Gynecol; 2022 Feb; 226(2):222.e1-222.e13. PubMed ID: 34534506
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
Dempster-Rivett K; Innes CR; Simcock BJ; Harker D; Williman JA; Van Der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Pather S; Wrede CD; Sykes PH
Am J Obstet Gynecol; 2020 Sep; 223(3):408.e1-408.e11. PubMed ID: 32109465
[TBL] [Abstract][Full Text] [Related]
3. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
4. Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
Krog L; Lycke KD; Kahlert J; Randrup TH; Jensen PT; Rositch AF; Hammer A
Am J Obstet Gynecol; 2024 Apr; 230(4):430.e1-430.e11. PubMed ID: 38569830
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
[TBL] [Abstract][Full Text] [Related]
6. Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.
Elfgren K; Elfström KM; Naucler P; Arnheim-Dahlström L; Dillner J
Am J Obstet Gynecol; 2017 Mar; 216(3):264.e1-264.e7. PubMed ID: 27825977
[TBL] [Abstract][Full Text] [Related]
7. Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study.
Matsumoto K; Hirai Y; Furuta R; Takatsuka N; Oki A; Yasugi T; Maeda H; Mitsuhashi A; Fujii T; Kawana K; Iwasaka T; Yaegashi N; Watanabe Y; Nagai Y; Kitagawa T; Yoshikawa H;
Int J Clin Oncol; 2012 Jun; 17(3):233-9. PubMed ID: 21748261
[TBL] [Abstract][Full Text] [Related]
8. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study.
Lycke KD; Kahlert J; Damgaard RK; Eriksen DO; Bennetsen MH; Gravitt PE; Petersen LK; Hammer A
Am J Obstet Gynecol; 2023 Dec; 229(6):656.e1-656.e15. PubMed ID: 37595822
[TBL] [Abstract][Full Text] [Related]
10. Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2-a prospective clinical multicenter cohort study.
Kylebäck K; Ekeryd-Andalen A; Greppe C; Björkenfeldt Havel C; Zhang C; Strander B
Am J Obstet Gynecol; 2022 Nov; 227(5):742.e1-742.e11. PubMed ID: 35777432
[TBL] [Abstract][Full Text] [Related]
11. Management of cervical intraepithelial neoplasia 2 in adolescent and young women.
Fuchs K; Weitzen S; Wu L; Phipps MG; Boardman LA
J Pediatr Adolesc Gynecol; 2007 Oct; 20(5):269-74. PubMed ID: 17868892
[TBL] [Abstract][Full Text] [Related]
12. Correlation of human papilloma virus infection with cytology, colposcopy and histopathological examination of the bioptic tissue in low- and high-grade intraepithelial lesions.
Jovanović AM; Dikic SD; Jovanovic V; Zamurovic M; Nikolic B; Krsic V; Rakic S; Stanimirovic B
Eur J Gynaecol Oncol; 2012; 33(5):512-6. PubMed ID: 23185799
[TBL] [Abstract][Full Text] [Related]
13. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.
Ryu KJ; Lee S; Min KJ; Kim JW; Hong JH; Song JY; Lee JK; Lee NW
Oncologist; 2015 Jun; 20(6):635-9. PubMed ID: 25964305
[TBL] [Abstract][Full Text] [Related]
14. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
TOMBOLA Group
BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
[TBL] [Abstract][Full Text] [Related]
15. Management of the low grade squamous intraepithelial lesion Pap smear in a cross-sectional, observational cohort.
Yoost JL; Goetzl L; Hoda R; Soper DE; Barry A
J Reprod Med; 2009 Jul; 54(7):421-4. PubMed ID: 19691257
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
[TBL] [Abstract][Full Text] [Related]
17. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G
Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019
[TBL] [Abstract][Full Text] [Related]
18. Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program.
Sahlgren H; Elfström KM; Lamin H; Carlsten-Thor A; Eklund C; Dillner J; Elfgren K
Am J Obstet Gynecol; 2020 Mar; 222(3):253.e1-253.e8. PubMed ID: 31585095
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.
Silver MI; Gage JC; Schiffman M; Fetterman B; Poitras NE; Lorey T; Cheung LC; Katki HA; Locke A; Kinney WK; Castle PE
Cancer Prev Res (Phila); 2018 Mar; 11(3):165-170. PubMed ID: 29437696
[TBL] [Abstract][Full Text] [Related]
20. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
van der Marel J; van Baars R; Rodriguez A; Quint WG; van de Sandt MM; Berkhof J; Schiffman M; Torné A; Ordi J; Jenkins D; Verheijen RH; Helmerhorst TJ; Ter Harmsel B; Wentzensen N; Del Pino M
Gynecol Oncol; 2014 Nov; 135(2):201-7. PubMed ID: 25204846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
